NEXT day delivery available - 3pm cut off
Worldwide shipping available
Free standard UK delivery on orders over £100
This article is intended for qualified aesthetic practitioners and prescribers. It is educational and does not replace formal training, product instructions for use or clinical judgement.
The Tyndall effect after filler is a blue-grey discolouration seen through the skin when hyaluronic acid (HA) gel sits too superficially. It is almost always a placement problem rather than a product defect, it shows up most often in the tear trough, perioral lines and lips, and unlike bruising it does not fade on its own within days. The good news for practitioners is that it is largely preventable with the right product, plane and volume, and it is manageable when it does happen.
Below we cover why it occurs, which areas and products carry the most risk, how to tell Tyndall apart from bruising or vascular compromise, and what a sensible prevention and management protocol looks like in a UK clinic.
The name comes from the 19th-century physicist John Tyndall, who described how particles suspended in a medium scatter light. Shorter blue wavelengths scatter more than longer red ones, which is why a colloid lit from the side can look faintly blue. HA filler behaves in a similar way. When a bolus or thread of gel lies in the superficial dermis or immediately under thin skin, incoming light is scattered by the gel, and the blue component is reflected back to the observer.
Three things make it more likely:
Migration and late swelling can also bring product closer to the surface over time, which is why some patients present months or even years after the original treatment.
The tear trough is the classic site. The skin is thin, the orbicularis is close to the surface and there is little subcutaneous fat to hide product. Superficial placement here, particularly with a firmer, more cross-linked gel, is the most common route to a tyndall effect under eye filler presentation. Deep placement on the periosteum or in the deep fat compartments, ideally with a blunt cannula, is the standard way to keep product out of view.
The tyndall effect lip filler pattern usually appears along the vermilion border or in fine perioral lines treated with a linear threading technique close to the surface. Lip filler is generally placed submucosally or in the body of the lip, so a blue line at the border suggests product sitting higher than intended. Small aliquots and a lighter gel help when treating fine lines.
Superficial correction of nasolabial folds, smoker's lines and the nasal dorsum can also show a blue cast, especially in patients with fair or thin skin.
Placement matters more than brand, but rheology still plays a part. Softer, more cohesive and lower-concentration HA gels are designed to integrate with tissue and are generally preferred where skin is thin. Products indicated for the infraorbital hollow, such as Restylane Eyelight with Lidocaine or Teosyal Redensity II PureSense, are formulated with this area in mind, but they still need correct depth and conservative volumes. You can compare the other options in our tear trough filler collection.
A few practical points when choosing product for high-risk zones:
Many practitioners favour a blunt cannula for the tear trough because it allows a single entry point and a controlled, deep pass along the orbital rim with reduced bruising. A cannula does not guarantee the correct plane, though. It can still be advanced superficially, so tactile feedback and a clear understanding of the layers remain essential. Our cannula range includes a choice of gauges and lengths suited to periorbital work.
Habits that reduce Tyndall risk:
"Is it a bruise or Tyndall?" is one of the most common questions patients ask after treatment, and it is worth having a clear answer for your aftercare conversations.
If there is any doubt between Tyndall and an evolving vascular event, treat it as a potential occlusion until proven otherwise.
Management depends on the severity, how long the product has been in place and the patient's wishes. The common approaches described in the literature are:
Where gel is very superficial and recently placed, a small puncture with a needle followed by gentle expression of the product has been described as a simple correction technique (Douse-Dean et al., 2008). This suits small, localised deposits rather than diffuse product.
For most persistent cases, dissolving the HA with hyaluronidase is the established approach, and it is discussed in published case reports such as this report on the management of the Tyndall effect. Hyaluronidase is a prescription-only medicine in the UK, so it must be prescribed by an appropriate independent prescriber following a face-to-face assessment, with consent covering the risk of allergy and loss of some native tissue fullness. Dosing, dilution and patch-testing decisions sit with the prescriber and local protocol.
Once the area has settled, many patients still want the original concern addressed. Re-treating at a deeper plane with a more suitable product, or choosing a non-filler approach for skin quality, usually gives a better outcome than adding more product on top of the problem.
Tyndall should be named in your consent form for any thin-skinned area, alongside bruising, swelling, lumps and vascular occlusion. Record the product, batch number, volume, depth, technique (needle or cannula) and injection points for every treatment. If a patient later presents with discolouration, good records let you, or another clinician, understand what was placed and where, which makes correction faster and safer.
Not reliably. Because it is caused by HA gel sitting superficially, it tends to persist for as long as the product remains, which can be many months or longer. Some cases fade gradually as the filler degrades, but most patients with a visible blue cast need active correction.
It can be visible immediately if product is placed very superficially, but it is often noticed once early swelling and bruising settle, typically within the first couple of weeks. Late presentations months or years after treatment are also seen, often linked to migration or accumulation of product.
The Tyndall effect itself is a cosmetic complication rather than a threat to tissue. The risk lies in confusing it with vascular compromise, which is an emergency. Any discolouration with blanching, mottling, pain or visual change should be managed as a possible occlusion.
Yes. A cannula reduces some risks, such as bruising, and makes a deep pass easier, but product can still be laid down too superficially if the cannula is in the wrong plane.
No HA filler is immune. Softer, more cohesive gels indicated for thin-skinned areas are generally preferred, but correct depth and conservative volume matter more than the product choice alone.
The Tyndall effect is a predictable complication of superficial HA placement, concentrated in the tear trough, lips and perioral area. Choosing a product suited to thin skin, placing it deep, using small volumes and reviewing before topping up will prevent most cases. When it does occur, distinguish it carefully from bruising and vascular compromise, document thoroughly, and refer to an appropriate prescriber for correction where needed. For the consumables and fillers that support a deep, controlled technique, browse our ranges for practitioners.
